Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization - Wikidata - awgldk - TriplyDB

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

http://www.wikidata.org/entity/Q28111719

about

Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review Current status of transarterial radioembolization Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer.Radioembolization for the treatment of hepatocellular carcinoma Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma.Intraarterial therapies for primary liver cancer: state of the art.How does selective internal radiation therapy compare with and/or complement other liver-directed therapies.(90)Y-glass microspheres for hepatic neoplasia.Transarterial approaches to primary and secondary hepatic malignancies.Value of quality of life analysis in liver cancer: A clinician's perspective Locoregional and systemic therapy for hepatocellular carcinoma.In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/ acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells.Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.Incorporating Quality of Life Metrics in Interventional Oncology Practice.Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.Hepatocellular carcinoma Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis

P2860

Q26743603-4632EEA9-10B6-4185-8C0F-CAC462984456 Q26744307-0BFF3F1B-E86C-4217-A330-74D481B87CCC Q26753024-389C896A-99D0-45F0-8EFD-92BA8859C2C9 Q26753089-491DE53B-6BE0-49A9-8FBF-DB4E23CA6BC9 Q26852174-3D841496-E034-4AEE-81DC-DB515EB6900E Q27007847-1CCCF976-9147-4ED2-98CE-F0665D74D35A Q27023616-78E5F22A-AF85-4520-A987-EC90E6CC83EA Q30248206-E08F345B-D7D2-49BB-9BA5-3A4886AC731D Q32173610-77E82647-A55D-4DFB-B0F5-DCB26CC5208A Q33872976-E3A89358-812D-48B0-BFBF-137E5244D348 Q33935237-BC03CB28-8AE4-4D57-AB1D-0275AE10DF3A Q34045215-EB97BA78-299F-45A0-B29F-9F8A4FB78850 Q34702094-B2343BB7-9014-48B1-B2E6-65EDB42E5073 Q35128190-5E017A93-CA42-4D78-937C-F8F739FA5450 Q35164855-B262542F-659B-44E5-AA83-65400AA1C8EB Q35631304-9EEB1EDA-29F9-4B98-9B16-D15ECF00884C Q36062588-0925B8D3-6A1B-49CA-9D80-D22453D112F4 Q36268905-573F2A07-64CF-461E-A8E2-F33DEF896391 Q36482781-E35CE79B-7F01-45A3-B678-E9884A0FAD24 Q37611108-A1A6CC0D-3F28-4C25-ABFE-D27F4D2AE77E Q38149993-1B0AC35B-A0DF-4392-A202-4CBC6988534E Q38283692-1D7163A8-31BB-4A5E-A488-52A089868748 Q38465831-8537E9C9-453F-43E1-9860-B3AF77CAA32B Q38488732-542CE462-E88A-4A02-9947-6905305054DA Q38626594-5CC89C6D-511F-44CC-8D37-8C00A5EE39DB Q38686790-2C27B640-4E08-4067-AB21-17005C3A775E Q38984450-E3461DEB-F93A-47C6-A791-00306E108283 Q41108851-94079414-9657-45A6-B008-5061C0B4C87F Q42378410-C693C0E4-1EF7-4936-B220-D9DB1AF86D9D Q47556433-6E2D0298-8617-493C-8815-9357488AE78D Q47573685-9B91E78C-0A78-4B09-A5FB-7B836996B122 Q48049674-33756F6B-CA32-4E34-9868-40B799075E58 Q48058236-080A4F07-3FE7-4079-A306-C7ED6975279B Q49627939-C51491CE-8BFA-4C82-88F8-514C93E420C9 Q53216812-C8E54CEB-0B29-4CD4-8B08-FEEEF81E1AF4 Q57756376-F75A974B-9513-4FD2-BEAC-1C2BEDC80665 Q58804965-D906E38C-658F-4274-B189-3FCD2FFAB3C5

P2860

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

http://www.wikidata.org/entity/Q28111719

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Increased Quality of Life Amon ...... ompared With Chemoembolization

@ast

Increased Quality of Life Amon ...... ompared With Chemoembolization

@en

Increased Quality of Life Amon ...... ompared With Chemoembolization

@nl

type

label

Increased Quality of Life Amon ...... ompared With Chemoembolization

@ast

Increased Quality of Life Amon ...... ompared With Chemoembolization

@en

Increased Quality of Life Amon ...... ompared With Chemoembolization

@nl

prefLabel

Increased Quality of Life Amon ...... ompared With Chemoembolization

@ast

Increased Quality of Life Amon ...... ompared With Chemoembolization

@en

Increased Quality of Life Amon ...... ompared With Chemoembolization

@nl

P1433

Q28111719-1E074922-3711-4A96-BCDE-3671817AA8E9

P1476

Q28111719-CA73D6C8-D48E-4B0B-8E81-97D1C178DCFA

P2093

Q28111719-07EE9766-D78D-4134-9B05-07DDF88A31BC

Q28111719-1F0E3FAC-4D07-4A8D-BEA0-B648D5D50145

Q28111719-1F4DFF82-47AF-4B00-86F6-800B516232F8

Q28111719-2D0D77CA-68BC-4E9A-8A0A-FC8088858131

Q28111719-64385819-FB0B-424E-814B-339C21EF58CC

Q28111719-6EEF51F0-E3E5-4B0C-86A4-6626BD50B7D4

Q28111719-B7834D5A-4E3E-4B64-9A50-73D4DBA57DC8

Q28111719-CDA8E165-2002-4160-94DA-AD7FCFE18B5A

Q28111719-D2C13C0E-920E-4D98-94C1-92FFA26A8855

Q28111719-D4546156-9A43-42EB-82F2-06C7045D8B61

P304

Q28111719-25D51070-E4AB-4039-87B4-CE1BBAF41308

P31

Q28111719-865E9183-34F2-449E-9F71-3D19CAB2EEC0

P3181

Q28111719-276BF2B7-0477-46E9-93EA-CDECE58EB452

P356

Q28111719-81169CDD-F136-4D12-8C4C-F239E9F46A88

P407

Q28111719-32B1D9AF-1079-4F63-9CF8-B0CF9D672BDB

P433

Q28111719-B523A8B7-2355-4F04-B75A-CB576E6BB8C3

P478

Q28111719-613F3419-438F-4745-8650-79EFB9813D3C

P50

Q28111719-5FF17AC3-F1C4-4295-9733-A06548F40E3D

Q28111719-6450C88A-60D5-4055-92BD-AD2966D0BEC1

Q28111719-99C1367F-17E3-4607-83C6-E68B9737E1CE

P577

Q28111719-CB6FE4ED-5659-4625-B554-B7B88242852E

P698

Q28111719-F3C37BD3-F4D9-4BA5-A45D-B3009D286E2B

P921

Q28111719-61E2D010-AFCD-4A2F-B992-3F4B19B61D17

P3181

P356

J.CGH.2013.04.028

P1433

Clinical Gastroenterology and Hepatology

P1476

Increased Quality of Life Amon ...... ompared With Chemoembolization

@en

P2093

Ahsun Riaz

http://www.w3.org/2001/XMLSchema#string

Al B. Benson

http://www.w3.org/2001/XMLSchema#string

Daniel Ganger

http://www.w3.org/2001/XMLSchema#string

James L. Burns

http://www.w3.org/2001/XMLSchema#string

Khairuddin Memon

http://www.w3.org/2001/XMLSchema#string

Laura Kulik

http://www.w3.org/2001/XMLSchema#string

Margaret Gilbertsen

http://www.w3.org/2001/XMLSchema#string

Mary F. Mulcahy

http://www.w3.org/2001/XMLSchema#string

Michael M. Abecassis

http://www.w3.org/2001/XMLSchema#string

Michael Vouche

http://www.w3.org/2001/XMLSchema#string

P304

1358-1365.e1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2421007

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CGH.2013.04.028

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23644386

http://www.w3.org/2001/XMLSchema#string

P921

quality of life